No Data
No Data
No Data
Teva Announces Collaboration to Commercialize Formycon's Biosimilar Candidate to Eylea (Aflibercept) in Major Parts of Europe and in Israel
Samsung Bioepis and Teva Enter Into a Strategic Partnership for Commercialization of EPYSQLI (Eculizumab-aagh) in the United States
National Bank on Andlauer Health -- Maintains Outperform,$58.75 Target
RBC Capital Markets Says Stella-Jones, Westshore Terminals 'Best-Positioned Stocks' In Canadian Trucking, Industrials Sector
RBC Capital Markets 2023 Canada Automotive, Industrials & Transportation Conference; 7th Of 10 Parts, Logistics
National Bank Cuts Price Target on Andlauer Healthcare Group as Forecast Lowered to Reflect Lower EBITDA Margin